Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia. (28th December 2015)

• Record Type: Journal Article
• Authors: Degwert, Nicole; Latuske, Emily; Vohwinkel, Gabi; Stamm, Hauke; Klokow, Marianne; Bokemeyer, Carsten; Fiedler, Walter; Wellbrock, Jasmin
• Is Part Of: European journal of haematology. Volume 97:Number 3(2016:Sep.)
• Page Start: 239
• Page End: 244
• Publication Date: 2015-12-28
• Subjects: Acute myeloid leukaemia -- hypoxia -- drug resistance -- deoxycytidine kinase -- hypoxia‐inducible factor 1 alpha; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; Blood -- Periodicals; 616.15005
• DOI: 10.1111/ejh.12711
• Languages: English
• ISSNs: 0902-4441

Abstract

Abstract: Objectives: Leukaemia initiating cells reside within specialised niches in the bone marrow where they undergo complex interactions with different stromal cell types. The bone marrow niche is characterised by a low oxygen content resulting in high expression of hypoxia‐inducible factor 1 α in leukaemic cells conferring a negative prognosis to patients with acute myeloid leukaemia (AML). Methods and Results: In the current study, we investigated the impact of hypoxic vs. normoxic conditions on the sensitivity of AML cell lines and primary AML blasts to cytarabine. AML cells cultured under 6% oxygen were significantly more resistant against cytarabine compared to cells cultured under normoxic conditions in proliferation and colony‐formation assays. Interestingly upon cultivation under hypoxia, the expression of the cytarabine‐activating enzyme deoxycytidine kinase was downregulated in all analysed AML cell lines and primary AML samples representing a possible mechanism for resistance to chemotherapy. Furthermore, the downregulation of deoxycytidine kinase could be associated with hypoxia‐inducible factor 1 α as treatment with its inhibitor BAY87‐2243 hampered the downregulation of deoxycytidine kinase expression under hypoxic conditions. Conclusions: In conclusion, our data reveal that hypoxia‐induced downregulation of deoxycytidine kinase represents one stroma‐cell‐independent mechanism of drug resistance to cytarabine in acute myeloid leukaemia.